Ohr Pharmaceutical Company Profile (NASDAQ:OHRP)

Analyst Ratings

Consensus Ratings for Ohr Pharmaceutical (NASDAQ:OHRP) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $21.50 (708.27% upside)

Analysts' Ratings History for Ohr Pharmaceutical (NASDAQ:OHRP)
Show:
DateFirmActionRatingPrice TargetActions
6/16/2016Roth CapitalReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Chardan CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Brean CapitalReiterated RatingBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Cowen and CompanyInitiated CoverageOutperform$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Ohr Pharmaceutical (NASDAQ:OHRP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/10/2016Q2($0.18)($0.17)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/10/2015Q415($0.20)($0.13)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q215($0.17)($0.12)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2015Q115($0.20)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/22/2014($0.10)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Ohr Pharmaceutical (NASDAQ:OHRP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.23)($0.23)($0.23)
Q4 20161($0.24)($0.24)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Ohr Pharmaceutical (NASDAQ:OHRP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Ohr Pharmaceutical (NASDAQ:OHRP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/20/2016Jason Scott SlakterCEOBuy8,786$2.85$25,040.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2016Samuel BackenrothCFOBuy2,468$2.84$7,009.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Jason Scott SlakterCEOBuy3,682$3.11$11,451.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016Jason Scott SlakterCEOBuy28,068$3.15$88,414.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016Samuel BackenrothCFOBuy2,500$3.17$7,925.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/11/2016Jason Scott SlakterCEOBuy6,250$3.35$20,937.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Jason Scott SlakterCEOBuy6,250$3.63$22,687.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2016Jason Scott SlakterCEOBuy6,250$3.11$19,437.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016Jason Scott SlakterCEOBuy6,250$3.62$22,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Jason Scott SlakterCEOBuy3,000$4.07$12,210.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Jason Scott SlakterCEOBuy13,350$3.00$40,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Irach B TaraporewalaCEOBuy3,705$6.75$25,008.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015June Sherie AlmenoffDirectorBuy6,000$6.75$40,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Samuel BackenrothCFOBuy1,500$6.75$10,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014June Sherie AlmenoffDirectorBuy2,200$8.08$17,776.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2014Ira A GreensteinDirectorBuy1,000$8.40$8,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2014June Sherie AlmenoffDirectorBuy3,200$8.34$26,688.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/25/2014Thomas M RiedhammerDirectorBuy6,900$7.39$50,991.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2014Ira A GreensteinDirectorBuy2,500$10.20$25,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2014June Sherie AlmenoffDirectorBuy5,500$10.25$56,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Ohr Pharmaceutical (NASDAQ:OHRP)
DateHeadline
07/22/16 05:30 PMTrading Examination: Performance check on Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - TGP
07/22/16 05:30 PMChecking in on Stock Volatility for: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Engelwood Daily
07/22/16 05:30 PMInsiders Increasing Positions in: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Press Telegraph
07/22/16 05:30 PMOhr Pharmaceutical Incorporated (NASDAQ:OHRP) Sellers Increased By 7.04% Their Shorts - Press Telegraph
07/22/16 05:30 PMTalking Trading: Active Stock Rundown for Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Press Telegraph
07/22/16 05:30 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 08:31 AMOhr Pharmaceuticals, Inc. (OHRP) Updated Price Targets - FTSE News
07/17/16 05:00 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Check on Sentiment Score - Press Telegraph
07/17/16 05:00 PMTrading Focus on Shares of: Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - TGP
07/17/16 05:00 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Earnings Review and Target Watch - TGP
07/17/16 05:00 PMBroker Outlook For The Week Ahead Ohr Pharmaceuticals, Inc. (OHRP) - Fiscal Standard
07/17/16 09:50 AMShares Moving Down on the Week: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Engelwood Daily
07/16/16 08:55 AMShares Experiencing a Downtrend: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - TGP
07/15/16 04:40 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 04:40 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Earnings and Ratings in Focus - Telanagana Press
07/15/16 10:40 AMStock Trading Action Review for: Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Telanagana Press
07/15/16 10:40 AMCurrent Sentiment and Impact Score Watch:Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP):Ohr Pharmaceuticals, Inc ... - Press Telegraph
07/14/16 05:56 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Analyst Average Stock Rating - Engelwood Daily
07/14/16 05:56 PMTrading Action Update: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Press Telegraph
07/13/16 05:58 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 05:58 PMActive Share Performance Review for: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Press Telegraph
07/12/16 05:53 PMEquity Review - Shares in Focus: Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Telanagana Press
07/12/16 05:53 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP): Recent Share Performance Watch - Press Telegraph
07/12/16 09:55 AMTarget Tracker and Earnings View for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
07/11/16 05:36 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Earnings Recap and Sell-side Recommendation Review - Telanagana Press
07/11/16 05:36 PMOhr Pharmaceutical Incorporated (NASDAQ:OHRP) Shorted Shares Increased By 2.85% - Press Telegraph
07/11/16 10:16 AMTrading Review - Company in Focus: Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Telanagana Press
07/11/16 10:16 AMImpact Score and Stock Sentiment Outlook :Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
07/11/16 10:16 AMStock Rating Watch and Earnings Insight for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
07/09/16 05:00 PMCan Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) Improve on the Earnings Front? - Engelwood Daily
07/09/16 05:00 PMOhr Pharmaceutical Incorporated (NASDAQ:OHRP) Shorted Shares Increased 2.85% After Market Selling - Press Telegraph
07/09/16 05:00 PMCompany Stock Focus for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP): Which Way Will Shares Head? - Press Telegraph
07/06/16 10:15 AMCurrent Stock Trading Roundup for: Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Telanagana Press
07/06/16 10:15 AMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/05/16 10:05 AMRecommendation View and Earnings Glance for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
07/05/16 10:05 AMOhr Pharmaceuticals, Inc. (OHRP) Broker Price Targets For The Coming Week - Fiscal Standard
07/01/16 05:38 PMOhr Pharmaceutical Incorporated (NASDAQ:OHRP) Sellers Increased By 2.85% Their Shorts - Press Telegraph
07/01/16 05:38 PMRecently Issued Stock Ratings For Ohr Pharmaceuticals, Inc. (OHRP) - Fiscal Standard
06/29/16 05:31 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Company Rating and Target Watch - Telanagana Press
06/29/16 05:31 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Stock Performance and Session Recap - Engelwood Daily
06/29/16 05:31 PMOhr Pharmaceuticals Inc. (OHRP) Jumps 6.18% on June 28 - Equities.com
06/28/16 05:34 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP): Reviewing Stock Performance - Press Telegraph
06/28/16 05:34 PMStock Performance in Review: Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Press Telegraph
06/27/16 05:35 PMOhr Pharmaceuticals, Inc. (NASDAQ:OHRP) Recent Performance and Company Stock Review - Engelwood Daily
06/27/16 05:35 PMShare Update and Earnings Review for Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
06/27/16 05:35 PMActive Company Share Review : Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) - Press Telegraph
06/27/16 09:48 AMWatching Stock Sentiment for:Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
06/26/16 04:48 PMStock Sentiment Review for :Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) - Press Telegraph
06/08/16 05:06 PMOhr Pharmaceutical, Inc. :OHRP-US: Earnings Analysis: Q2, 2016 By the Numbers : June 8, 2016 -
05/19/16 12:04 PMOHR PHARMACEUTICAL INC Financials -

Social

About Ohr Pharmaceutical

Ohr Pharmaceutical logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OHRP
  • CUSIP:
Key Metrics:
  • Previous Close: $2.66
  • 50 Day Moving Average: $2.71
  • 200 Day Moving Average: $3.18
  • P/E Ratio: N/A
  • P/E Growth: -0.03
  • Market Cap: $84.41M
  • Beta: 1.31
  • Current Year EPS Consensus Estimate: $-1.39 EPS
  • Next Year EPS Consensus Estimate: $-1.98 EPS
Additional Links:
Ohr Pharmaceutical (NASDAQ:OHRP) Chart for Thursday, July, 28, 2016